Dynamic changes in thrombin generation in abdominal sepsis in mice

Shock

Volumn 42, Issue 4, 2014, Pages 343-349

  Wang, Yongzhi ^a   ÖBraun, Oscar ^b   Zhang, Su ^a   Luo, Lingtao ^a   Norström, Eva ^a   Thorlacius, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b Department of Clinical Sciences Section for Cardiology   (Sweden)

Author keywords

Coagulation; Inflammation; Platelets; Prothrombin

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; CILASTATIN PLUS IMIPENEM; MYELOPEROXIDASE; PROTHROMBIN; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HISTOLOGY; LEUKOPENIA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PLASMA FACTOR; PROTEIN BLOOD LEVEL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE POOR PLASMA; THROMBOCYTOPENIA; TISSUE INJURY; ABDOMEN; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE;

ABDOMEN; ANIMALS; BLOOD COAGULATION FACTORS; MALE; MICE; MICE, INBRED C57BL; SEPSIS; THROMBIN;

EID: 84914684643     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000215     Document Type: Article

References (35)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554, 2003.
2. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R: Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 311(13):1308-1316, 2014.
3. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, et al.: Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5(1):31-41, 2007.
4. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM: Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42(8):1749-1755, 2014.
5. Bhatia M, Zemans RL, Jeyaseelan S: Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol 46(5):566-572, 2012.
6. Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, van Deursen P, van Kerkhoff L, van Gemen B, ten Cate H, et al.:The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96(2):554-559, 2000.
7. Levi M, van der Poll T: The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin Thromb Hemost 34(5):459-468, 2008.
8. Shaw AD, Vail GM, Haney DJ, Xie J, Williams MD: Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis. J Crit Care 26(6):539-545, 2011.
9. Semeraro N, Ammollo CT, Semeraro F, Colucci M: Sepsis, thrombosis and organ dysfunction. Thromb Res 129(3):290-295, 2012.
10. Yamaguchi K, Majima M, Katori M, Kakita A, Sugimoto K: Preferential consumption of coagulation factors I, V, and VIII in rat endotoxemia. Shock 14(5):535-543, 2000.
11. Van Dreden P, Woodhams B, Rousseau A, Dreyfus JF, Vasse M: Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure. Clin Chem Lab Med 51(2):387-396, 2013.
12. Ratinier M, Caporale M, Golder M, Franzoni G, Allan K, Nunes SF, Armezzani A, Bayoumy A, Rixon F, Shaw A, et al.: Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog 7(12):e1002477, 2011.
13. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC: Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 9(9):1713-1723, 2011.
14. Kashuk JL, Moore EE, Wohlauer M, Johnson JL, Pezold M, Lawrence J, Biffl WL, Burlew CC, Barnett C, Sawyer M, et al.: Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion 52(1):23-33, 2012.
15. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ: Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 52(3): 355-361, 2010.
16. Picoli-Quaino SK, Alves BE, Faiotto VB, Montalvao SA, De Souza CA, Annichino-Bizzacchi JM, De Paula EV: Impairment of thrombin generation in the early phases of the host response of sepsis. J Crit Care 29(1):31-36, 2014.
17. Collins PW, Macchiavello LI, Lewis SJ, Macartney NJ, Saayman AG, Luddington R, Baglin T, Findlay GP: Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135(2):220-227, 2006.
18. Petros S, Kliem P, Siegemund T, Siegemund R: Thrombin generation in severe sepsis. Thromb Res 129(6):797-800, 2012.
19. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A: Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Intensive Care Med 38(8):1326-1335, 2012.
20. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 29(2):189-201, 1980.
21. Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, Petersen LC, Piantadosi CA: Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med 167(9):1200-1209, 2003.
22. Wang Y, Roller J, Slotta JE, Zhang S, Luo L, Rahman M, Syk I, Menger MD, Thorlacius H: Distinct patterns of leukocyte recruitment in the pulmonary microvasculature in response to local and systemic inflammation. Am J Physiol Lung Cell Mol Physiol 304(4):L298-L305, 2013.
23. Dargaud Y, Spronk HM, Leenders P, Hemker HC, Ten Cate H: Monitoring platelet dependent thrombin generation in mice. Thromb Res 126(5):436-441, 2010.
24. Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H: Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg 250(5):783-790, 2009.
25. Remick DG: Pathophysiology of sepsis. Am J Pathol 170(5):1435-1444, 2007.
26. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699-709, 2001.
27. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, et al.: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286(15): 1869-1878, 2001.
28. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, et al.: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290(2):238-247, 2003.
29. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S: The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32(5-6): 249-253, 2002.
30. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S: Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33(1):4-15, 2003.
31. Khan MM, Liu Y, Khan ME, Gilman ML, Khan ST, Bromberg M, Colman RW: Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. Am J Physiol Heart Circ Physiol 298(2):H652-H658, 2010.
32. Esmon CT: The regulation of natural anticoagulant pathways. Science 235(4794):1348-1352, 1987.
33. Finney SJ, Evans TW: Emerging therapies in severe sepsis. Thorax 57 (Suppl 2):II8-II14, 2002.
34. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT: The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95(5):1680-1686, 2000.
35. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345(6):408-416, 2001.